Acular (Ketorolac Tromethamine Ophthalmic) - Summary

ACULAR SUMMARY

ACULAR^®
(ketorolac tromethamine ophthalmic solution) 0.5%
sterile

ACULAR® (ketorolac tromethamine ophthalmic solution) is a member of the pyrrolo-pyrrole group of nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use. Its chemical name is (±)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)

ACULAR® ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. ACULAR® ophthalmic solution is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.

ACULAR NEWS HIGHLIGHTS

Media Articles Related to Acular (Ketorolac Ophthalmic)

The Online Cough Clinic's Spectacular Success: Check Out Your Chronic Cough On The Internet, With Expert Advice At Your Fingertips!
Source: Respiratory / Asthma News From Medical News Today [2008.10.06]

Treatment For Diabetic Macular Edema - Results From The Six-Month Interim Readout Of The Human PK Iluvien Study
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.10.03]

Researchers To Study Depression And Disability In Age-Related Macular Degeneration Patients
Source: Depression News From Medical News Today [2008.10.02]

VEGF Trap-Eye: New Data Confirm Successes In The Treatment Of Age Related Macular Degeneration
Source: Eye Health / Blindness News From Medical News Today [2008.09.30]

VEGF Trap-Eye Final Phase 2 Results In Age-related Macular Degeneration Presented At 2008 Retina Society Meeting
Source: Eye Health / Blindness News From Medical News Today [2008.09.29]

more>>

Published Studies Related to Acular (Ketorolac Ophthalmic)

Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]

Clinical evaluation of novel buccoadhesive film containing ketorolac in dental and post-oral surgery pain management. [2007.10]

In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. [2007.09]

Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification. [2007.07]

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. [2006.09]

more>>

Clinical Trials Related to Acular (Ketorolac Ophthalmic)

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity [Enrolling by invitation]

Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery [Completed]

Topical 0.4% Ketorolac and Vitreoretinal Surgery [Completed]

Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-Operative Cystoid Macular Edema. [Active, not recruiting]

Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK [Completed]

more>>